tadalafil dosage - viagra - augmentin uses - http://sildenafilgeneric-citrate.com/ - levitra 20mg vs viagra 100mg - furosemide for dogs - lisinopril hctz - cialis generic - gabapentin 300mg - doxycycline hyclate 100mg

Latest News

Plandai Biotechnology, Inc. Molecularly Changing the Botanical Extract Industry

Plandai Biotechnology, Inc. Molecularly Changing the Botanical Extract Industry

Written by ι Stock Market Media Group Staff — May 8, 2013

That loud noise coming from the botanical extract industry is Plandaí Biotechnology, Inc. (OTCQB: PLPL) landing on the scene with three highly bioavailable products that will likely change the way we look at botanical extracts for years to come.  This Seattle based biotechnology firm uses a proprietary process that is dramatically improving the bioavailability of their compounds through molecular changes to the live botanicals themselves.  So much so, that when the company’s products hit the market it will almost be unfair to its competition.

Plandaí Biotechnology is unlike just about any company you’ll run across from their technology, to their business model right down to their multi-branded product Phytofare™.  While the company is headquartered in Seattle, Washington, the heart of what makes this company tick is more than ten-thousand miles away on an 8,000 acre tea plantation in South Africa.  Plandaí grows its own botanicals, harvests them, and then once harvested, quickly passes the live plant materials on to the next phase of the process.  You see this company is fully integrated and everything is handled inside the company leaving no outside influences to disturb or hijack the process from start to finish.

It is the “magic” that takes place after the live plant materials are passed along to the next step in the process that will earn this company its stripes in the industry.  After all, Plandaí Biotechnology is a biotech firm and this is where they’ll prove it.  When anyone takes a drug or supplement of any kind, they want it to work and to get the most out of that compound into their system.  Well, this is what Plandaí is doing with its products – molecularly creating more bioavailable extracts for its customers.  Bioavailability can be defined as a measurement of the amount of any compound to be absorbed into the bloodstream. 

Through a patented hydrodynamic sheering process, live plant-materials are converted at the molecular level during extraction into a nano-particle structure that mimics that found in human tissues.  So, where most botanical products have less than ten percent absorption, according to the company and documented research, Phytofare™ is clinically proven to have far superior absorption.  Plandaí Biotechnology will offer its Phytofare™ product branded with three distinct labels and all offering the same high absorption rate: 

  • Phytofare™ Catechin Extract
  • Phytofare™ Limonoid Glycoside Complex
  • Phytofare™ Carotenoid Extract

The company’s CEO, Roger Duffield, eloquently explains Plandaí’s proprietary process, and while in journalism school all students learn only to use a quote in a story when the person speaking can say it better than you ever could.  Well, when they put away the farming equipment and don the lab coats to start the hydrodynamic sheering process, it’s clear the CEO makes the science much more understandable:

“Nearly all drug compounds are synthesized plant analogs. While botanical material can have tremendous curative properties, it generally has poor bioavailability—or low absorption in human tissues. This is because human tissues have a different molecular structure than plant matter.  A synthetic drug tries to recreate the beneficial elements using a molecule that has greater bioavailability.  Unfortunately, these synthetics often have adverse side effects and, over time, can result in drug-resistant strains of the disease.

 Our patented technology allows us to take specific types of live plant material and unzip the molecules, releasing all of the phytonutrients, and then rearrange the isomeric properties of the molecule so that it achieves up to a 50/50 ratio commonly found in human tissues.  Simultaneously, we’re able to take out any undesirable elements and reduce the particles to mainly nano-sized.

What this means is that we are able to tailor design the living molecule to maximize the phytonutrient properties and absorption.  So, where most phytonutrients are poorly absorbed in humans, often less than 10%, our products are highly absorbed. 

The key for us is using live plant materials.  From the moment of harvest, we maintain the material at an optimal temperature and then begin the extraction process within the hour.  This ensures that we are releasing and capturing live anti-oxidants, resulting in a product that is 100 percent pure bioactive. 

We believe that this technology is the foundation for creating a whole new family of drugs that can treat a multitude of diseases and conditions, safely and affordably using naturally-derived extracts.”

The CEO believes so strongly in the company’s technology and Plandaí’s ability to give its customers much higher absorption rates with its extracts that he created two new subsidiaries.  In addition to the three extract products branded under the Phytofare™ name, Roger Duffield has created Phyto Pharmacare, Inc. which is licensed to develop and market Phytofare™ based botanical antioxidants for the pharmaceutical industry, and Phyto Nutricare, PLC which is licensed to develop and market Phytofare™ based botanical extracts for the nutriceutical industry. 

It will be through the company’s three Phytofare™ branded products and its two new subsidiaries that the extract industry will learn of the many heightened benefits these extracts can offer with the much improved bioavailability.  The products will all address a number of the most talked about areas in the industry including:  cancer prevention, anti-viral protection, anti-inflammation, antioxidants, weight loss, high blood pressure, and sports injury recovery.

The benefit to those using Plandaí’s products is that with higher bioavailability or absorption rate, a smaller dose is needed, and this allows the company to remain extremely competitive in the market.

Imagine finally buying a product that can actually deliver on its promised health claims.  This is what Plandaí’s highly bioavailable extracts will offer the market.  When introduced, the company will sell its extracts to the leading product manufacturers in the following sectors:  Food & Beverage, Cosmeceutical, Wellness, Nutraceutical, Anti-Aging, and Pharmaceutical.